Short-term supplementation with pioglitazone, an insulin sensitizing agent that stimulates PPAR-γ, to offspring from obese mothers attenuated the programmed obesity and insulin resistance associated with maternal obesity [124]. Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.